Inhibitors of cyclin-dependent kinase 7 (cdk7)
US-2026035393-A1 · Feb 5, 2026 · US
Syros Pharmaceuticals Inc holds 79 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 79 |
| Recent patents | 13 |
| First publication | Feb 4, 2016 |
| Latest publication | Feb 5, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026035393-A1 · Feb 5, 2026 · US
US-12364664-B2 · Jul 22, 2025 · US
US-12240869-B2 · Mar 4, 2025 · US
US-2024360165-A1 · Oct 31, 2024 · US
US-2024269076-A1 · Aug 15, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026035393-A1 · Feb 5, 2026 · US
US-12364664-B2 · Jul 22, 2025 · US
US-12240869-B2 · Mar 4, 2025 · US
US-2024360165-A1 · Oct 31, 2024 · US
US-2024269076-A1 · Aug 15, 2024 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 64 |
| A61K45/06 | 44 |
| A61K31/506 | 30 |
| C07D417/14 | 24 |
| C07D401/14 | 23 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 78 |
| Chemistry & Metallurgy | 73 |
| Physics | 3 |
| Cross-Sectional Technologies | 1 |
Answers are generated from the same data shown on this page.